-
Something wrong with this record ?
Dual kidney transplant: a single-center experience and review of the literature
P. Balaz, S. Rokosny, P. Wohlfahrt, M. Wohlfahrtova, M. Adamec, L. Janousek, J. Fronek, O. Viklicky, E. Pokorna,
Language English Country Turkey
Document type Journal Article, Review
NLK
Free Medical Journals
from 2003
Freely Accessible Science Journals
from 2003
Medline Complete (EBSCOhost)
from 2011-12-01
ROAD: Directory of Open Access Scholarly Resources
from 2003
PubMed
24128132
DOI
10.6002/ect.2013.0040
Knihovny.cz E-resources
- MeSH
- Acute Disease MeSH
- Time Factors MeSH
- Tissue Donors supply & distribution MeSH
- Kaplan-Meier Estimate MeSH
- Humans MeSH
- Delayed Graft Function etiology mortality MeSH
- Graft Survival MeSH
- Graft Rejection etiology mortality MeSH
- Retrospective Studies MeSH
- Risk Factors MeSH
- Aged MeSH
- Kidney Transplantation adverse effects methods mortality MeSH
- Donor Selection * MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Geographicals
- Czech Republic MeSH
OBJECTIVES: Adult dual kidney transplant is a strategy to overcome the imbalance between limited nephron mass supplied from an older donor and a recipient with a metabolic request. MATERIALS AND METHODS: In our report, we review the literature and present our single-center experience. From June 2007 until July 2012, nine hundred twenty-eight single and seventeen dual kidney transplants from deceased donors were performed. RESULTS: The average donor was 71.5 ± 3.6 years of age with an average serum creatinine, creatinine clearance, and an average number of sclerotic glomeruli, 106.1 ± 44.2 μmol/L, 0.97 ± 0.37 mL/s, and 22.4 ± 14.2. Immediate graft function and acute rejection episodes were observed in 75% and 6% of patients. The overall patient survival rates at 1 and 2 years after transplant were 93%. The overall graft survival rates at 1 and 2 years were 88%. CONCLUSIONS: Previous studies and our single-center experience suggest that the dual transplant procedure may help improve results of kidney transplants from expanded criteria donors and extend the donor pool by using kidneys that would be discarded otherwise.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14063895
- 003
- CZ-PrNML
- 005
- 20140709114810.0
- 007
- ta
- 008
- 140704s2013 tu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.6002/ect.2013.0040 $2 doi
- 035 __
- $a (PubMed)24128132
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a tu
- 100 1_
- $a Balaz, Peter $u Department of Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 245 10
- $a Dual kidney transplant: a single-center experience and review of the literature / $c P. Balaz, S. Rokosny, P. Wohlfahrt, M. Wohlfahrtova, M. Adamec, L. Janousek, J. Fronek, O. Viklicky, E. Pokorna,
- 520 9_
- $a OBJECTIVES: Adult dual kidney transplant is a strategy to overcome the imbalance between limited nephron mass supplied from an older donor and a recipient with a metabolic request. MATERIALS AND METHODS: In our report, we review the literature and present our single-center experience. From June 2007 until July 2012, nine hundred twenty-eight single and seventeen dual kidney transplants from deceased donors were performed. RESULTS: The average donor was 71.5 ± 3.6 years of age with an average serum creatinine, creatinine clearance, and an average number of sclerotic glomeruli, 106.1 ± 44.2 μmol/L, 0.97 ± 0.37 mL/s, and 22.4 ± 14.2. Immediate graft function and acute rejection episodes were observed in 75% and 6% of patients. The overall patient survival rates at 1 and 2 years after transplant were 93%. The overall graft survival rates at 1 and 2 years were 88%. CONCLUSIONS: Previous studies and our single-center experience suggest that the dual transplant procedure may help improve results of kidney transplants from expanded criteria donors and extend the donor pool by using kidneys that would be discarded otherwise.
- 650 _2
- $a akutní nemoc $7 D000208
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a opožděný nástup funkce štěpu $x etiologie $x mortalita $7 D051799
- 650 12
- $a výběr dárců $7 D046148
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a rejekce štěpu $x etiologie $x mortalita $7 D006084
- 650 _2
- $a přežívání štěpu $7 D006085
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a Kaplanův-Meierův odhad $7 D053208
- 650 _2
- $a transplantace ledvin $x škodlivé účinky $x metody $x mortalita $7 D016030
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a dárci tkání $x zásobování a distribuce $7 D014019
- 650 _2
- $a výsledek terapie $7 D016896
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Rokosny, Slavomir
- 700 1_
- $a Wohlfahrt, Peter
- 700 1_
- $a Wohlfahrtova, Mariana
- 700 1_
- $a Adamec, Milos $7 gn_A_00001257
- 700 1_
- $a Janousek, Libor
- 700 1_
- $a Fronek, Jiri
- 700 1_
- $a Viklicky, Ondrej
- 700 1_
- $a Pokorna, Eva
- 773 0_
- $w MED00174388 $t Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation $x 2146-8427 $g Roč. 11, č. 5 (2013), s. 388-95
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24128132 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140704 $b ABA008
- 991 __
- $a 20140709115102 $b ABA008
- 999 __
- $a ok $b bmc $g 1031379 $s 862627
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 11 $c 5 $d 388-95 $i 2146-8427 $m Experimental and clinical transplantation $n Exp Clin Transplant $x MED00174388
- LZP __
- $a Pubmed-20140704